使用TGF-β/PD-L1双特异抗体和武装型病毒疗法对感冒瘤进行免疫重编程
Yuchen Sun1, Shengtao Hu1, Ming Yi1
1Department of Breast Surgery, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
概括
新的组合免疫疗法,包括TGF-β/PD-L1双特异性抗体和型病毒,克服瘤微环境的抗性. 这些策略激活免疫力,并显示出个性化癌症治疗的前景.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 癌症研究 癌症研究
背景情况:
- 免疫疗法已经改变了癌症治疗,但由于免疫抑制瘤微环境 (TME) 而面临限制.
- 对当前免疫疗法的耐药性是瘤学中的一个重大挑战.
- 经过TME,通常会阻碍单剂疗法的有效性.
研究的目的:
- 综合结合免疫疗法策略的最新进展.
- 突出克服TME介导抗性的新方法.
- 讨论结合特定治疗平台以提高疗效的潜力.
主要方法:
- 综合免疫疗法近期临床前研究的综述.
- 专注于转变生长因子β/编程死亡连接体1 (TGF-β/PD-L1) 双特异抗体平台 (YM101/BiTP).
- 在组合策略中分析多细胞因子武装的型病毒VG161.
主要成果:
- 组合策略,特别是YM101/BiTP和VG161,显示出优异的临床前活动.
- 这些方法有效地拆除了TME内的免疫抑制网络.
- 观察到先天性免疫激活和TME重塑,克服了抵抗机制.
结论:
- 合理设计的组合免疫疗法可以克服TME诱导的耐药性.
- 整合机械洞察力和基于生物标志物的方法至关重要.
- 这些进展为个性化组合免疫疗法的新时代铺平了道路.
相关概念视频
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K